MacroGenics Inc logo

MGNX - MacroGenics Inc News Story

$13.25 -0.1  -1.0%

Last Trade - 19/01/22

Sector
Healthcare
Size
Mid Cap
Market Cap £602.9m
Enterprise Value £383.1m
Revenue £85.3m
Position in Universe 3085th / 7398

BRIEF-Macrogenics Announces Flotetuzumab Publication In Blood Advances

Thu 15th October, 2020 9:46pm
Oct 15 (Reuters) - MacroGenics Inc  MGNX.O :
    * MACROGENICS ANNOUNCES FLOTETUZUMAB PUBLICATION IN BLOOD
ADVANCES

Source text for Eikon:  ID:nGNX1czMN1 
Further company coverage:  MGNX.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.